These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21719866)

  • 1. Further enhancement of facial appearance with a hydroquinone skin care system plus tretinoin in patients previously treated with botulinum toxin Type A.
    Schlessinger J; Kenkel J; Werschler P
    Aesthet Surg J; 2011 Jul; 31(5):529-39. PubMed ID: 21719866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits of using a hydroquinone/tretinoin skin care system in patients undergoing intense pulsed light therapy for photorejuvenation: a placebo-controlled study.
    Woodhall KE; Goldman MP; Gold MH; Biron J
    J Drugs Dermatol; 2009 Sep; 8(9):862-7. PubMed ID: 19746679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
    Grimes P; Watson J
    Cutis; 2013 Jan; 91(1):47-54. PubMed ID: 23461059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of hydroquinone-free and hydroquinone-based hyperpigmentation regimens in treating facial hyperpigmentation and photoaging.
    Fabi SG; Goldman MP
    J Drugs Dermatol; 2013 Mar; 12(3):S32-7. PubMed ID: 23545931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementary effects of topical antiaging treatments in conjunction with aesthetic procedures.
    Bruce S
    J Drugs Dermatol; 2008 Feb; 7(2 Suppl):s23-7. PubMed ID: 18404868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigator-Blinded, Single-Center Study to Evaluate the Efficacy and Tolerability of a 4% Hydroquinone Skin Care System Plus 0.02% Tretinoin Cream in Mild-to-Moderate Melasma and Photodamage.
    Rendon M; Dryer L
    J Drugs Dermatol; 2016 Apr; 15(4):466-75. PubMed ID: 27050702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.
    Makino ET; Herndon JH; Sigler ML; Gotz V; Garruto J; Mehta RC
    J Drugs Dermatol; 2012 Dec; 11(12):1478-82. PubMed ID: 23377519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of a novel multimodality hydroquinone-free skin brightener over six months.
    Bruce S
    J Drugs Dermatol; 2013 Mar; 12(3):S27-31. PubMed ID: 23545930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.
    Makino ET; Mehta RC; Garruto J; Gotz V; Sigler ML; Herndon JH
    J Drugs Dermatol; 2013 Mar; 12(3):s21-6. PubMed ID: 23545929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel approach to the treatment of hyperpigmented photodamaged skin: 4% hydroquinone/0.3% retinol versus tretinoin 0.05% emollient cream.
    Draelos ZD
    Dermatol Surg; 2005 Jul; 31(7 Pt 2):799-804. PubMed ID: 16029670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance and efficacy of a product containing ellagic and salicylic acids in reducing hyperpigmentation and dark spots in comparison with 4% hydroquinone.
    Dahl A; Yatskayer M; Raab S; Oresajo C
    J Drugs Dermatol; 2013 Jan; 12(1):52-8. PubMed ID: 23377328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mequinol 2%/tretinoin 0.01% solution: an effective and safe alternative to hydroquinone 3% in the treatment of solar lentigines.
    Jarratt M
    Cutis; 2004 Nov; 74(5):319-22. PubMed ID: 15605971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating photodamage of the décolletage area with a novel copper zinc malonate complex plus hydroquinone and tretinoin.
    Leyden JJ; Parr L
    J Drugs Dermatol; 2010 Mar; 9(3):220-6. PubMed ID: 20232582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized, Investigator-Blinded Comparison of Two Topical Regimens in Fitzpatrick Skin Types III-VI With Moderate to Severe Facial Hyperpigmentation.
    Vanaman Wilson MJ; Jones IT; Bolton J; Larsen L; Wu DC; Goldman MP
    J Drugs Dermatol; 2017 Nov; 16(11):1127-1132. PubMed ID: 29141061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, controlled comparative study of the wrinkle reduction benefits of a cosmetic niacinamide/peptide/retinyl propionate product regimen vs. a prescription 0.02% tretinoin product regimen.
    Fu JJ; Hillebrand GG; Raleigh P; Li J; Marmor MJ; Bertucci V; Grimes PE; Mandy SH; Perez MI; Weinkle SH; Kaczvinsky JR
    Br J Dermatol; 2010 Mar; 162(3):647-54. PubMed ID: 20374604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facilitating facial retinization through barrier improvement.
    Draelos ZD; Ertel KD; Berge CA
    Cutis; 2006 Oct; 78(4):275-81. PubMed ID: 17121065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical tolerance and efficacy of capryloyl salicylic acid peel compared to a glycolic acid peel in subjects with fine lines/wrinkles and hyperpigmented skin.
    Oresajo C; Yatskayer M; Hansenne I
    J Cosmet Dermatol; 2008 Dec; 7(4):259-62. PubMed ID: 19146601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Safety and Efficacy of Treatment With a 1,927-nm Diode Laser With and Without Topical Hydroquinone for Facial Hyperpigmentation and Melasma in Darker Skin Types.
    Vanaman Wilson MJ; Jones IT; Bolton J; Larsen L; Fabi SG
    Dermatol Surg; 2018 Oct; 44(10):1304-1310. PubMed ID: 29659405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nail staining from hydroquinone cream.
    Ozluer SM; Muir J
    Australas J Dermatol; 2000 Nov; 41(4):255-6. PubMed ID: 11105373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Evaluation of a 4% Hydroquinone + 1% Retinol Treatment Regimen for Improving Melasma and Photodamage in Fitzpatrick Skin Types III-VI.
    Rendon MI; Barkovic S
    J Drugs Dermatol; 2016 Nov; 15(11):1435-1441. PubMed ID: 28095558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.